Evidence map›Paper›PMID 40567940›Full record

ArticleNeuroimage. Reports2024

Validation of a semi-automated method to quantify lesion volume changes in multiple sclerosis on 2D proton-density-weighted scans based on image subtraction.

Rozemarijn M Mattiesing, Serena Stel, Alysha S Mangroe, Iman Brouwer, Adriaan Versteeg, Ronald A van Schijndel, Bernard M J Uitdehaag, Frederik Barkhof, Hugo Vrenken, Joost P A Kuijer

Abstract read
In one paragraph

Article in Neuroimage. Reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rozemarijn M MattiesingMS Center Amsterdam, Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam UMC location VUmc, De Boelelaan 1118, 1081 HZ, Amsterdam, the Netherlands.
Serena StelMS Center Amsterdam, Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam UMC location VUmc, De Boelelaan 1118, 1081 HZ, Amsterdam, the Netherlands.
Alysha S MangroeMS Center Amsterdam, Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam UMC location VUmc, De Boelelaan 1118, 1081 HZ, Amsterdam, the Netherlands.
Iman BrouwerMS Center Amsterdam, Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam UMC location VUmc, De Boelelaan 1118, 1081 HZ, Amsterdam, the Netherlands.
Adriaan VersteegMS Center Amsterdam, Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam UMC location VUmc, De Boelelaan 1118, 1081 HZ, Amsterdam, the Netherlands.
Ronald A van SchijndelMS Center Amsterdam, Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam UMC location VUmc, De Boelelaan 1118, 1081 HZ, Amsterdam, the Netherlands.
Bernard M J UitdehaagMS Center Amsterdam, Neurology, Amsterdam Neuroscience, Amsterdam UMC location VUmc, De Boelelaan 1118, 1081 HZ, Amsterdam, the Netherlands.
Frederik BarkhofMS Center Amsterdam, Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam UMC location VUmc, De Boelelaan 1118, 1081 HZ, Amsterdam, the Netherlands.
Hugo VrenkenMS Center Amsterdam, Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam UMC location VUmc, De Boelelaan 1118, 1081 HZ, Amsterdam, the Netherlands.
Joost P A KuijerMS Center Amsterdam, Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam UMC location VUmc, De Boelelaan 1118, 1081 HZ, Amsterdam, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The detection and quantification of changes in white matter lesions in the brain is important to monitor treatment effects in patients with multiple sclerosis (MS). Existing automatic tools predominantly require FLAIR images as input which are not always available, or only focus on new/enlarging activity. Therefore, we developed and validated a semi-automated method to quantify lesion volume changes based on 2D proton-density (PD)-weighted images and image subtraction. This semi-automated method provides insight in both "positive" activity (defined as new and enlarging lesions) and "negative" activity (disappearing and shrinking lesions). Methods: Yearly MRI scans of patients with early MS from the REFLEX/REFLEXION studies were used. The maximum follow-up period was 5 years. Two PD-weighted images were normalized, registered to a common halfway-space, intensity-matched, and subsequently subtracted. Within manual lesion masks, lesion changes were quantified using a subtraction intensity threshold and total lesion volume change (TLVC) was calculated. Reproducibility was measured by assessing transitivity, specifically, we calculated the intraclass correlation coefficient for the absolute agreement (ICC Results: Reproducibility was excellent, with ICC Discussion: The semi-automated method to quantify lesion volume changes has excellent reproducibility and overall good accuracy. The amount of atrophy and especially lesion volume (change) should be taken into account when applying this method, as an increase in these variables might affect the quality of the results. Conclusion: Overall, the semi-automated subtraction method allows a valid and reliable quantitative investigation of lesion volume changes over time in (early) MS for follow-up periods up to 5 years.

Indexed as

Image subtractionLesion volume changesMagnetic resonance imagingMultiple sclerosisSemi-automated segmentationWhite matter lesions

Identifiers

PMID40567940
PMCPMC12172906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.